Technology

AcelRx Pharmaceuticals

$1.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ACRX and other stocks, options, and ETFs commission-free!

About ACRX

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA. The listed name for ACRX is AcelRx Pharmaceuticals, Inc. Common Stock.

CEO
Vincent J. Angotti
Employees
99
Headquarters
Redwood City, California
Founded
2005
Market Cap
192.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.27M
High Today
$1.92
Low Today
$1.81
Open Price
$1.89
Volume
6.37M
52 Week High
$2.94
52 Week Low
$0.7014

Collections

ACRX Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, After Hours

You May Also Like

GNRSW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure